Please login or sign up to post and edit reviews.
7: Dealcast: Covid-19 and healthcare M&A
Media Type |
audio
Categories Via RSS |
Business
Business News
News
Publication Date |
Apr 29, 2020
Episode Duration |
00:18:26
No sector is closer than healthcare to the front-lines of the covid-19 pandemic.
Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A.
In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review